________________________________________________________

                     Securities and Exchange Commission
                            Washington, DC 20549
            ________________________________________________________

                                   FORM  10-K

MARK ONE:
[X]  ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 for the Fiscal Year Ended December 31, 1999; or

[  ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.

                       Commission File No. 0-38593

                    RENAISSANCE CAPITAL PARTNERS II, LTD.
           (Exact name of registrant as specified in its charter)

           TEXAS                                               75-2407159
(State of incorporation or organization)                    (I.R.S. Employer
                                                          Identification No.)

      5646 MILTON STREET, SUITE 900
           DALLAS, TEXAS                                             75206
(Address of principal executive offices)                            (Zip Code)

Registrant's telephone number, including area code:   (214) 378-9340

Securities Registered Pursuant to Section 12(b) of the Act:

                                                   Name of each exchange
Title of each class                                 on which registered
      NONE                                                 NONE

            Securities Registered Pursuant to Section 12(g) of the Act:

                              LIMITED PARTNERSHIP INTERESTS
                               SUBSCRIPTION UNITS OF $1000
                                    (Title of class)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days:
Yes [X]    No [  ]

Indicate by check mark if disclosure by delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to
this Form 10-K:          [X]

State the aggregate market value of the voting stock held by non affiliates of
the registrant:

As of December 31, 1999, there were 43,254 Units of Limited Partnership
Interest outstanding.  A Unit is an initial offering Subscription of $1,000.
There is no market in the Units.  Based on Unit values as reflected in the
Registrant's Financial Statements, the aggregate value of the Partnership
Interests held by non-affiliates as of December 31, 1999, was $16,645,209.
Aggregate value of the Partnership Interests held by affiliates as of December
31, 1999, was $57,391.


                                      PART  I

The discussion set forth herein contains certain forward looking statements
with respect to the financial condition, results of operations and business of
the Partnership.  These forward looking statements are subject to certain
risks and uncertainties, not all of which can be predicted or anticipated.
Factors that may cause actual results to differ materially from those
contemplated by the forward looking statements herein include, but are not
limited to, changes in economic conditions;  competitive conditions in the
markets in which portfolio companies conduct their operations, including
competition from companies with substantially greater resources than those of
the portfolio companies; and the results of litigation, which cannot be
predicted with certainty.  Readers of this Discussion should not place undue
reliance on forward looking statements.

ITEM 1.  BUSINESS

GENERAL DEVELOPMENT OF BUSINESS
Renaissance Capital Partners II, Ltd. (sometimes referred to as the
"Registrant" or the "Partnership") is a Texas limited partnership, (organized
as of January 14, 1991, with commencement of operations on January 6, 1992),
that has elected to operate as a business development company (sometimes
referred to herein as a "Business Development Company" or a "BDC") under the
Investment Company Act of 1940, as amended (the "1940 Act").  On January 23,
1991, the Partnership filed a registration statement on Form N-2 for the sale
of up to 50,000 Limited Partnership Units at an offering price of $1,000 per
Unit.  The Partnership continued the offering until March 31, 1993, at which
time the offering was closed.

The investment objective of the Partnership was to provide investors with
current income and long-term capital appreciation by investing primarily in
private placement convertible debt securities (the "Debentures") of small and
medium size public companies ("Portfolio Companies").  The Partnership's
stated goal was to achieve a 10% annual current return to the holders of
limited partnership interests (the "Interests"); provided, however, that such
current return was to be increased or decreased from time to time, dependent
upon the actual operating results of the Partnership.  The Partnership is not
currently paying an annual return to the Partners and does not anticipate
doing so prior to the final liquidation of the Partnership.
Renaissance Capital Group, Inc. ("Renaissance Group"), a Texas corporation,
served as the managing general partner (the "Managing General Partner") and as
investment adviser to the Partnership until September 30, 1998.  In those
capacities, Renaissance Group was primarily responsible for the selection,
evaluation, structure, and administration of the Partnership's investment
portfolio.  Renaissance Group is a registered investment adviser under the
Investment Advisers Act of 1940, as amended (the "Advisers Act") and the Texas
Securities Act.  However, those activities were subject to the supervision of
two Independent General Partners of the Partnership who provided guidance with
respect to the operations of the Partnership (the "Independent General
Partners") (See Item 10.  Directors and Executive Officers of the Registrant).

Generally, investments were made in companies that have their common stock
registered for public trading under the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or that have made arrangements, satisfactory to
the Partnership, for commencement of such registration in conjunction with the
financing.  The terms of the documents evidencing the Partnership's investment
("Portfolio Investments") in Portfolio Companies generally provide that the
Partnership will have the right to convert its Debentures into or otherwise
acquire common stock in exchange for its Debentures.  Each was a direct
placement with the Portfolio Company.

Accordingly, while such common stock of the Portfolio Company may be publicly
traded, the common stock to be acquired by the Partnership is generally
unregistered.  Therefore, such securities are restricted from distribution or
sale to the public except in compliance with certain holding periods and
exemptions under the Securities Act of 1933, as amended (the "Securities
Act"), or after registration pursuant to the Securities Act.

On January 6, 1992, the minimum offering requirements had been met and the
first closing of sale of Units occurred in the amount of $2,808,000.
Following the initial closing, the Partnership commenced carrying forward its
plan of business operations.  The Partnership directed its investment efforts
to small and medium sized Portfolio Companies.

Effective October 1, 1998, Renaissance Group withdrew as Managing General
Partner of the Partnership as part of an agreement to begin to wind down and
liquidate the Partnership.  Mr. Thomas W. Pauken, who had served as an
Independent General Partner agreed to become the Liquidation Trustee (the
"Trustee") pursuant to the Liquidation Trustee's Agreement which was filed as
an Exhibit to Form 10-Q for the period ending September 30, 1998, and is
incorporated for all purposes herein.  The Trustee assumed all
responsibilities, and has the authority, of the Managing General Partner.

Pursuant to the provisions of the Partnership Agreement, the Trustee commenced
to wind up the affairs of the Partnership and to liquidate its assets.  The
Trustee has full right and unlimited discretion to determine the time required
and used for liquidation, including sale of assets, distribution of assets in
kind, and exchange of assets for other assets for the purpose of obtaining, in
its opinion, fair value for such assets, having due regard to the activity and
condition of the relevant matters of general financial and economic
conditions.  To the extent that such assets cannot be liquidated, the Trustee,
subject to the Securities Act and the 1940 Act, may effectuate an in-kind
distribution if it would be in the best interests of the Partners and if in
accordance with the Prospectus.  To the extent permitted by the Advisers Act,
for all purposes of this Agreement, assets distributed in kind shall be deemed
to have been sold for their fair market, and the proceeds of such sale shall
be deemed to have been distributed as of the date of the in-kind distribution.
It was the Trustee's initial objective to wind up the Partnership by the year
2001 and distribute the assets, other than the monies necessary to conclude
any pending litigation (see Item 3.  Legal Proceedings).  However, in light of
the positive developments that have taken place this year in the Tutogen
Medical, Inc. ("Tutogen") investment, the Trustee believes that the
distribution of all of the shares of Tutogen to the Partners in 2000 would not
necessarily serve the objective of maximizing the value of the remaining
assets in the Partnership (see Liquidation Policy below). The Trustee wants to
ensure that the Partnership maintains its ability, through substantial stock
ownership of Tutogen, to influence the affairs of the Company.  The Trustee
joined the Board of Directors of Tutogen in 1999 and has taken an active role
in the business of the Company as the representative of the Partnership.  He
intends to remain on the Board in 2000.  Hopefully, all of the shares or the
proceeds thereof, of Tutogen can be distributed to the Partners by 2001 or
sooner if Tutogen merges or is acquired by another company; however, no such
transaction is pending as of the date of this report.

FINANCIAL INFORMATION ABOUT INDUSTRY SEGMENTS
While the Partnership originally had a diversified portfolio in a variety of
industries, it is concentrated now in the biotech/medical products industry
due to the fact that Tutogen Medical, Inc., the one remaining active company
in the portfolio, is a biotech/medical products company.

NARRATIVE DESCRIPTION OF THE BUSINESS
The Partnership, as a Business Development Company under the 1940 Act,
primarily made investments in convertible debentures of small and medium sized
public companies.  The Partnership substantially completed making new
investments by 1998.

Under the provisions of the 1940 Act, a Business Development Company must
invest at least 70% of its funds in "eligible portfolio investments", such
being generally defined as direct placements to eligible companies and
temporary investments in "cash items" pending other investments.  However,
under the provisions of the 1940 Act, a Business Development Company may
invest up to 30% of its funds in "Other Investments" that is, investments that
do not qualify as "eligible portfolio investments", such as open market
purchases or participation in public offerings. The Trustee does not intend to
make any new investments in additional companies.

At December 31, 1999, the Partnership's investment assets were classified by
amount as follows:
<TABLE>
<CAPTION>
									                                                    Percentage of
Classification                             Cost          Investments (at cost)
<S>                                         <C>                    <C>
Eligible Portfolio Companies             $8,066,598               100%

Other Portfolio Companies                   None                   0%
</TABLE>

INVESTMENT OBJECTIVE
The investment objective of the Partnership was to provide its Limited
Partners with both current income and long-term capital appreciation.

LIQUIDATION POLICY
The investment objective of the Trustee is to wind up the Partnership in an
expeditious manner while seeking to maximize the value of the remaining assets
and reduce the administrative and managerial costs to the Partnership.

In 1998, $1,000,000 was distributed to the Limited Partners.

REGULATION UNDER THE INVESTMENT COMPANY ACT OF 1940
The 1940 Act was enacted to regulate investment companies.  In 1980, the 1940
Act was amended by the adoption of the Small Business Investment Incentive
Act.  The purpose of the amendment was to remove regulatory burdens on
professionally managed investment companies engaged in providing capital to
smaller companies.  The Small Business Investment Incentive Act established a
new type of investment company specifically identified as a Business
Development Company as a way to encourage financial institutions and other
major investments to provide a new source of capital for small developing
businesses.

BUSINESS DEVELOPMENT COMPANY

A Business Development Company ("BDC")

(1)  is a closed-end management company making 70% of its investments only in
certain companies (identified as "Eligible Portfolio Companies"), and in "cash
items" pending other investments.  Under the regulations established by the
SEC under the 1940 Act only certain companies may qualify as "Eligible
Portfolio Companies".  Qualifications to be met for a company to be an
"Eligible Portfolio Company" are:
(a) it must be organized under the laws of a state or states of the United
States, (b) it may not be an investment company (except for a wholly owned
Small Business Investment Company), and (c) it must generally fall into one or
the three following categories:
1. Companies that do not have a class of securities registered on a national
securities exchange or are the Federal Reserve OTC margin list,
2. Companies that are actively controlled by the BDC either alone or as part
of a group (for this purpose, control is presumed to exist if the BDC or group
in which the BDC is a member owns 25% or more of the voting securities), or
3. It meets such other criteria as established by the SEC.

(2)  must be prepared to provide "Significant Managerial Assistance" to such
Portfolio Companies.  Significant Managerial Assistance means, as to the
Partnership:
(a) any arrangement whereby the Partnership, through its officers, employees
or General Partners, seeks to provide significant guidance concerning
management, operations, objectives or policies of the Portfolio Company, or
(b) the exercise of a controlling influence over the Portfolio Company.

Further, the regulations generally provide that the securities must be
obtained in direct transactions with the Portfolio Company and as such are
generally restricted from transferability in the public markets.

1940 ACT REQUIREMENTS
The BDC election exempts the Partnership from some provisions of the 1940 Act.
However, except for those specific provisions, the Partnership will continue
to be subject to all provisions of the 1940 Act not exempted, including the
following:
(1) restrictions on the Partnership from changing the nature of business so as
to cease to be, or to withdraw its election as, a BDC without the majority
vote of the Interests;
(2) restrictions against certain transactions between the Partnership and
affiliated persons;
(3) restrictions on issuance of senior securities, such not being prohibited
by the 1940 Act but being restricted as a percentage of capital;
(4) compliance with accounting rules and conditions as established by the SEC,
including annual audits by independent accountants;
(5) compliance with fiduciary obligations imposed under the 1940 Act;
(6) requirement that the Limited Partners ratify the selection of the
Partnership's independent public accountants and the approval of the
investment advisory or similar contracts and amendments thereto; and
(7) restrictions on purchases of Units by the Partnership.

PARTNERSHIP TERM
The Partnership Agreement provides for a term of eight (8) years from the
final closing of the initial offering which was March 31, 1993.  As of October
1, 1998, Thomas W. Pauken was appointed the Liquidation Trustee to wind up the
affairs of the Partnership and liquidate its assets.

PARTNERSHIP PORTFOLIO INVESTMENTS
As of December 31, 1999, the Partnership had five (5) Portfolio investments of
which one (1) was active.

TOTAL CHOICE, INC.(FORMERLY AMERISHOP, CORP. (PRIVATELY HELD))
Total Choice, Inc. provides incentive merchandising and membership buying
programs.  The Partnership originally made an investment in July 20, 1992 in
Amerishop, Inc. ("Amerishop") of Grand Rapids, Michigan.

Effective June 18, 1997, the Partnership and AmeriShop entered into a
"Surrender Agreement" and "Bill of Sale and Omnibus Agreement" whereby the
Partnership foreclosed on all the assets of the business of AmeriShop, except
for receivables pledged on senior debt and any proceeds thereof, in exchange
for cancellation of all Convertible Debentures and Notes held by the
Partnership.

The Partnership valued the surrendered assets at $700,000 and transferred them
into Total Choice, Inc. ("Total Choice"), a newly formed Texas corporation, in
exchange for a 60% common equity interest in the new entity.  The Partnership
recognized a $3,028,448 loss on the foreclosure transaction.  In July 1997,
the Partnership made a $300,000 follow-on investment to Total Choice in the
form of Preferred Stock.

A valuation reserve of $196,065 was placed on this investment representing the
Partnership's 60% share of the Company's $326,775 loss for 1997.

In 1998, the Partnership received no revenues from the new business, now known
as Total Choice, Inc.  In 1999, the Partnership received no revenues from
Total Choice, Inc.  The Partnership has completely written down this
investment, and the Trustee believes that, in the absence of major operational
changes and the infusion of additional capital by other investors in the
existing business, which is not currently expected, the Partnership is
unlikely to realize any value in this investment.

TUTOGEN MEDICAL, INC. (formerly known as Biodynamics International, Inc.)
Formerly known as Biodynamics International, Inc., the Company ("Tutogen")
processes bio implants for neurosurgical, orthopedic, urological,
reconstructive and general surgical indications, utilizing its patented
Tutoplast process of tissue preservation and viral inactivation.  Tutogen's
products are distributed worldwide through operating subsidiaries in the U.S.
and Germany and through strategic alliances with such companies as Mentor and
I.O.P., Inc. Tutogen stock trades on the NASDAQ stock market under the symbol
TTGN.

On March 29, 1993, the Partnership invested $2,500,000 in a 11% convertible
debenture issued by Tutogen.  Subsequently, the Partnership made follow-on
investments in Tutogen.

In 1998, Tutogen rolled a $500,000 Promissory Note into a convertible
debenture ("Debenture 2") with the debenture being convertible into shares of
common stock at $1.35 per share.  Throughout fiscal year 1998 which ended
September 30, 1998, Tutogen met its interest obligation on Debenture 2 and the
$2,074,081 Debenture ("Debenture 1") to the Partnership by issuing shares of
common stock.  Thereafter, the Company began making its interest payments on
Debenture 2 in cash.  The company is current on its interest payments on
Debenture 2.

In 1999, the Partnership became the majority shareholder of Tutogen pursuant
to a series of transactions involving the recapitalization of Tutogen.  These
transactions included the conversion of a Tutogen debenture, the amendment of
stock purchase warrants held by the Partnership and the issuance of additional
common stock of Tutogen to the Partnership in exchange for assets of the
Partnership.  Effective January 31, 1999, the Partnership and Tutogen entered
into several inter-related transactions, as follows:
(i) the Partnership exercised its right to convert the ouststanding principal,
accrued interest and accrued expenses on a convertible debenture in the
principal amount of $2,074,081 in accordance with the terms of the debenture,
resulting in the issuance to the Partnership of 4,600,507 shares and, as
additional consideration for the agreement to convert the debenture, the
Company issued to the Partnership an additional 149,334 shares;
(ii) warrants held by the Partnership to purchase 1,353,957 shares were
amended.  These warrants previously were subject to exercise prices of $2.50
and $2.60 per share; as amended, the exercise prices of the warrants are $1.25
per share if the warrants are exercised prior to June 30, 2000.  If not so
exercised, the exercise prices will revert to the original exercise prices of
the warrants; and (iii) the Partnership acquired 300,000 shares, together
with warrants to purchase additional 300,000 shares at an exercise price of
$1.50 per share, in exchange for $300,000 cash.

On December 22, 1999, the Partnership sold 9,500 shares of common stock at
$3.25.  The average cost of this stock was $12,401, and the net proceeds
received by the Partnership for this sale is $30,300.

As of December 31, 1999, the Partnership was the beneficial owner of 8,159,777
shares, representing approximately 62.4% of the outstanding shares of the
Company (including, for this purpose shares issued in transactions described
above and shares issuable upon exercise of warrants and upon conversion of a
debenture owned by the Partnership; all of the warrants and the debenture are
presently convertible or exercisable).

Revenues for fiscal year 1998 was approximately $9 million, and net earnings
for fiscal year 1998 were approximately $287,000.

Fiscal year 1999 was a much better year for Tutogen.  Under the leadership of
the new CEO, Manfred Krueger, Tutogen increased its revenues to $11.464
million and reported a net income for the year of $414,000.  Particularly
noteworthy were the results of the fourth quarter of fiscal year 1999 when net
income was $1,024,000 or 9 cents per share, compared to net earnings of
$287,000 or 5 cents per share for the same period in fiscal year 1998.  In
1999, revenues were up, cash flow was positive, margins improved
significantly, and G&A costs as a percentage of revenues were down.  The
Company's business with Mentor Corporation continues to grow with much
improved margins to the Company as a result of a new distribution agreement
that has been negotiated with Mentor.  Tutogen's Tutoplast(R) product is used
in Mentor's sling procedure, a surgical operation that addresses the problem
of incontinence in women.  The demand for that product has been strong.

Tutogen also hopes to enter into a strategic alliance with a medical company
specializing in orthopedics to market and distribute Tutogen's Spinal
Interbody Spacer made of Tutoplast(R) material.

Subsequent to December 31, 1999, the partnership received principal payments
of $9,950 on a debenture owed by Tutogen.

CODED COMMUNICATIONS CORPORATION
Coded Communications Corporation, Carlsbad, California ("Coded") was a
manufacturer of digital transmission systems for mobile fleet operations.  On
October 9, 1992, the Partnership invested $2,500,000 in a 12% convertible
debenture issued by Coded.  Subsequently, the Partnership made follow-on
investments in Coded.

During the first quarter of 1998, Coded announced that Gary Luick had resigned
as President and Chief Executive Officer, and Director of Coded.  The Company
also announced that Hugo Camou, Chairman of the Board, would be assuming
responsibilities as Chief Executive Officer, and that John Wiggins, Chief
Operating Officer, would become President and take Mr. Luick's place on the
board. Coded also announced that it had completed a two-year financial
restructuring of its unsecured debt by making a final payment of $613,000
under the San Diego Credit Settlement Plan.  Overall, the Plan settled $1.65
million dollars and was carried out over a 27-month period, during which time
Coded made all payments as scheduled.  On January 14, 1998, Coded announced
that it had established a revolving line of credit with Comerica Bank for up
to $1.75 million, including a capital equipment credit line for up to
$250,000.

By the second quarter of 1998, the Company was in a working capital crisis and
in the third quarter the Partnership fully reserved its investment in the
preferred and common stock of the Company.

In the fourth quarter of 1998, Coded filed for bankruptcy in Chapter 11
proceedings in Delaware.  That was converted to Chapter 7 status in the first
quarter of 1999.  The Trustee took legal action to try to protect the
Partnership's secured position on the portion of its investment in Coded
represented by a $311,060 Promissory Note. (see Item 3.  Legal Proceedings)

In the third quarter ended September 30, 1999, the Partnership received
proceeds of $385,000 from the Estate of Coded for payment in full of a
Promissory Note and our interest in the Company.  In the third quarter of
1999, the Partnership accrued expenses of $50,000 to cover anticipated legal
fees. (see Item 3.  "Legal Proceedings" for certain information regarding
litigation instituted by the Trustee on behalf of the Partnership.)

CONSOLIDATED HEALTH CARE ASSOCIATES, INC.
Consolidated Health Care Associates, Inc. ("CHCA") operated physical therapy
rehabilitation centers until it was liquidated in 1998.  On December 29, 1992,
the Partnership invested $2,500,000 in an 11% debenture issued by CHCA of
Franklin, Massachusetts. Subsequently, the Partnership made follow-on
investments in CHCA.

Thereafter, in 1997 and 1998, the Partnership made additional advances to CHCA
in the form of various promissory notes. (see 1998 Form 10-K).

As of December 31, 1998, the Company owed Renaissance $1,119,938 plus unpaid
interest in the amount of $58,861 on the 8% Promissory Note dated February 1,
1998, and also owed the Partnership $63,000 plus unpaid interest in the amount
of $7,482 on the 15% Promissory Note dated March 6, 1998.

In March 1998, CHCA assigned remaining payments of two notes owed to CHCA to
the Partnership.  The Trustee did collect $24,138 in payments in the fourth
quarter of 1998 on one Note owed to CHCA whose payments were assigned to the
Partnership.  During 1999, the Trustee collected $28,960 in payments on this
note.  As of December 31, 1999, the principal balance is $79,415.  Payments
under the second Note assigned to the Partnership of $5,641 were still due as
of December 31,  1998, but were collected by the Trustee in the first quarter
of 1999.

It is asserted that Renaissance's security position on the $1,119,938 and
$63,000 Notes is currently inferior to the position of a factoring company
which is collecting on the accounts receivable of the liquidated entity.  At
this time, barring litigation, it is unlikely that the Partnership will be
able to collect anything further on those Notes in light of the asserted
priority claims of the factoring company and the limited assets of the
Company.

TRICOM CORPORATION
Tricom Corporation ("Tricom") was engaged in LAN construction, telephone line
construction auditing, parking meter auditing and the provision of coin box
services for the pay telephone and parking meter industries.  On November 11,
1992, the Partnership invested $1,000,000 in a 12% convertible debenture
issued by Tricom of Santa Monica, California as the first disbursement under a
$2,000,000 loan agreement. Subsequently, the Partnership made follow-on
investments in Tricom.

In the first quarter of 1998, Tricom sold Office Communications Systems, Inc.
("OCS"), its wholly owned subsidiary to AIDCO, Inc. The stock purchase
agreement called for Tricom to receive $1,350,000 for its ownership interest
in OCS.  Of the $1,350,000 sale price, $1,150,000 was paid to Tricom, while
the remaining $200,000 balance was deposited into an escrow account to be held
for a period of 12 months from closing as security for the indemnification
obligations of Tricom pursuant to the stock purchase agreement.

Effective May 28, 1998, the Partnership entered into an Agreement with the
Company whereby the Partnership converted its preferred stock having a cost
basis of $2,153,600 into 538,400 shares of the Company's common stock having a
cost basis of $2,203,600, bringing the Partnership's total ownership interest
to 26.7%, and the Company agreed to pay the Partnership $150,000 plus a non-
interest-bearing Promissory Note for $50,000 due December 31, 1999.  In
addition, the Company agreed to expand its Board to allow for a Partnership
representative and to reduce the salary of Art Truckenbrodt, the Company's
President and Chief Officer to $70,000.  By June 30, 1998, $75,000 had been
received from the Company, and in the third quarter of 1998 an additional
$75,000 was received from the Company.

The Partnership fully reserved its investment in the Company as of September
30, 1998, and the Company is now out of business.  It is doubtful at this time
that the Partnership will be able to collect on the $50,000 Promissory Note
due from the Company or realize any additional value for this investment.

PERSONNEL
The Partnership has no direct employees but instead has contracted with the
Trustee pursuant to the Partnership Agreement to provide all management and
operation activities.  The Trustee currently employs one additional person to
assist him in performing the duties and functions required by the Partnership.
Outside personnel are retained by the Trustee on an as needed basis.  At the
present time, a substantial portion of the Trustee's staff time is devoted to
activities of the Partnership.

FINANCIAL INFORMATION ABOUT FOREIGN AND DOMESTIC OPERATIONS
A substantial amount of business of Tutogen Medical, Inc., arises out of the
operations of its German subsidiary.  Since there are no additional
investments planned by the Partnership, there will be no additional
investments in foreign operations.

ITEM 2.  PROPERTIES

The Partnership's business activities are conducted from the leased offices of
the Trustee in an office building in Dallas.  Certain office expenses relating
to the Partnership's activities are charged to the Partnership by the Trustee
pursuant to the Liquidation Trustee Agreement made effective on October 1,
1998, and as an Exhibit in Form 10-Q for the period ending September 30, 1998.

ITEM 3.  LEGAL PROCEEDINGS

The Trustee has filed a lawsuit on behalf of the Partnership against the
former Directors of Coded Communications Corporation and others alleging
securities fraud, fraud, negligent misrepresentation and other claims to the
detriment of the Partnership.  That lawsuit is pending in the United States
District Court for the Northern District of Texas, Dallas Division and is
styled "Thomas W. Pauken, Liquidation Trustee for Renaissance Capital Partners
II, Ltd. v. Hugo Camou, et al.; Civil Action No. 3-98-CV-2758-G".  The Trustee
also filed certain actions on behalf of the Partnership in the Coded
Communications Chapter 7 bankruptcy styled "IN RE Coded Communications
Corporation, et al., Debtor; Bk. Case No. 98-2741 (MFW) through 98-2743
(MFW)".   The bankruptcy action was resolved in with a payment of $385,000 to
the Partnership in the third quarter of 1999.  The lawsuit is still pending in
the federal court lawsuit.  A portion of the cause of action has been referred
to arbitration in California.

The Partnership also appealed a decision of a Pennsylvania court in a
adversial action against the controlling shareholder of U.S. Fax in a case
styled "Renaissance Capital Partners II, Ltd v. US Fax, Inc. et al." That
appeal was successful in 1999.  The outcome of that litigation should have no
material effect on the Partnership.  There are no other legal proceedings
currently pending with regard to the Partnership.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matter was submitted to a vote of Limited Partners, through the
solicitation of proxies or otherwise, during the fourth quarter of 1999.

                                   PART   II

ITEM 5.  MARKET FOR THE REGISTRANT'S SECURITIES

TRADING
There is no trading in the Interests and no established market exists.
Interests are restricted from transfer except in the event of death or by
action of law or except with the prior approval of the Liquidation Trustee.

NUMBER OF HOLDERS
As of  December 31, 1999, there were approximately 1,825 beneficial holders of
Limited Partnership Interests.

DIVIDEND POLICY
The Partnership Agreement provided for an initial distribution to be made to
the Limited Partners within 30 days after the end of the first quarter
following closing of the offering, and thereafter, within 30 days of the end
of each subsequent quarter, with the amount of the distributions to be
determined at the discretion of the General Partners.  It was generally the
intention of the General Partners to distribute investment income net of
expenses on a quarterly basis.  Further, distributions of capital gains were
to be made as realized.

As the result of decreasing cash resources in 1995 and 1996, the distributions
to the limited partners were discontinued.  In 1997, $1,000,000 was
distributed to the Limited Partners.  In the fourth quarter of 1998, a $1
million distribution was made to the Limited Partners.  As the Partnership's
investments are liquidated, the Trustee expects to distribute to the Partners
cash and/or shares of stock.  In 1999, there were no distributions to the
Limited Partners.

ITEM 6.  SELECTED FINANCIAL DATA

The following selected  financial data for the five year period ended December
31, 1999, should be read in conjunction with the Partnership's Financial
Statements and notes thereto and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" included in Item 7 of this
Annual Report on Form 10-K for the five years ended December 31, 1999.
<TABLE>
<CAPTION>
                           1999         1998         1997          1996         1995
<S>                         <C>          <C>         <C>            <C>          <C>
Gross Income (Loss)
 (including realized
  losses)                401,197       66,373       243,921    (3,098,478) (3,349,784)

Net Unrealized
  appreciation
 (depreciation)
   on investments       8,841,095   (5,087,413)  (10,630,309)   1,049,091   1,443,065

Net Income (loss)       8,864,368   (5,622,192)  (11,106,609)  (3,000,121) (2,825,200)

Income (loss) per
Ltd Partnership unit        205        (130)        (253)          (68)        (64)

Total Assets           16,780,546    7,917,415    14,631,365    26,933,422  29,92,591

Distributions to
  Partners                 -0-       1,000,000    1,000,000        -0-       600,000

Distributions per Ltd
Partnership unit           -0-          23             23          -0-          14
</TABLE>

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

GENERAL
The purpose of the Partnership was to provide growth capital to small and
medium size public companies whose ability to service debt is sufficient to
provide a quarterly return to the Limited Partners and whose growth potential
is sufficient to provide opportunity for above average capital appreciation.

SOURCES OF OPERATING INCOME
Generally, the major source of operating income for the Partnership is
investment income, either in the form of interest on debentures or dividends
on stock.  However, the majority of income is derived from interest and
capital gains.  The Partnership generally sought to structure investments to
obtain an interest return competitive with current long-term financing rates
available from other sources.

Further, the Partnership, in some cases, received payments fees, drawn-down
fees and similar types of income.

While it was the general principle that the Managing General Partner and its
officers and directors occupy a fiduciary relationship to the Partnership and
not receive outside compensation or advantage in conflict with that
relationship, neither the Managing General Partner nor its officers and
directors were prohibited from receiving other income from non-conflicting
sources.  Neither is the Trustee prohibited from receiving other income that
is not in conflict with his fiduciary responsibilities to the Partnership.

The former Managing General Partner has formed other investment funds to make
investments in similar Portfolio Companies and may, in the future, form
additional similar investment funds.  Specifically, Renaissance Group formed
Renaissance Capital Partners, Ltd. ("Renaissance I"), a limited partnership,
and raised net capital contributions of approximately $12,886,000 in a private
placement offering for the purposes of making primarily convertible debenture
investments in small and medium size public companies.  Renaissance I is
currently fully invested.  The former Managing General Partner has also formed
Renaissance Capital Growth & Income Fund III, Inc. ("Renaissance III"), which
is also a BDC with investment objectives similar to those of the Partnership
and completed an offering in 1994 that raised approximately $41,489,500
available for investment.  At December 31, 1998, Renaissance III had completed
investments in twenty companies having an aggregate cost value of $46,242,647
of which eighteen are still active.  The Fund is actively seeking additional
investment opportunities.  In the Spring of 1996, Renaissance Group formed
Renaissance US Growth & Income Trust PLC ("RUSGIT") a public limited company
registered in England and Wales, listed on the London Stock Exchange, which
invests in privately placed convertible debentures issued by companies similar
to the investments of the Partnership.  RUSGIT invests primarily on a pari-
passu basis with Renaissance III.  In 1996, RUSGIT raised investment capital
of approximately $30,789,000.  At December 31, 1998, RUSGIT had made
investments in seventeen (17) portfolio companies having an aggregate cost
value of $28,301,665, of which sixteen (16) are still active.  RUSGIT, like
Renaissance III, continues to actively seek investment opportunities.  In
addition, Renaissance Group and its subsidiaries may, from time to time,
provide investment advisory services, management consulting services and
investment banking services to other clients.

As of October 1, 1998, Renaissance Group ceased serving as the Managing
General Partner and the Investment Advisor of the Partnership.

REGULAR QUARTERLY PAYMENTS TO PARTNERS/PRIORITY DISTRIBUTIONS

QUARTERLY PAYMENTS TO LIMITED PARTNERS
It was intended that cash payments from operations be made to all Limited
Partners each quarter to provide them a cash return.  Generally, this cash
distribution was to be made from profits and investment income.  However, in
the event that net profits were not adequate from time to time, the quarterly
distributions may be made from capital, so long as capital was sufficient to
assure repayment of all obligations of the Partnership and such capital
distributions were permitted by applicable partnership law and the 1940 Act.

Such distributions are currently permitted under the Revised Texas Limited
Partnership Act and under the 1940 Act, provided that, under the Revised Texas
Limited Partnership Act, distributions cannot be made if Partnership assets
are not sufficient to pay Partnership obligations and Limited Partners may be
liable for the repayment of distributions, if any received in contravention of
this restriction.

Further, quarterly distributions may be increased or decreased from time to
time to reflect increases or decreases in current rates of investment income.

As the result of decreasing cash resources in 1995 and 1996, the distributions
to the Limited Partners were discontinued. In 1997, $1,000,000 in
distributions were made to the Limited Partners.   In 1998, $1,000,000 in
distributions were made to the Limited Partners.  In 1999, there were no
distributions to the Limited Partners.  In light of the current financial
condition of the Partnership and the decision to proceed forward with final
liquidation of the Partnership, it is unlikely that the Trustee will re-
establish any regular distribution to the Limited Partners.

OPTIONAL DISTRIBUTIONS OF OPERATING PROFITS AND CAPITAL GAINS
In addition to the regular quarterly distributions, it was intended that, as
the Partnership achieves operating profits and net capital gains or realizes
increased portfolio values such as through stock distributions or exchanges,
such increased values, profits and gains may become available for distribution
to the Partners in cash or assets.

The Performance Distributions cannot be adjusted without the consent of all
the Limited Partners, except if required by order of a regulatory agency.

During 1998, the Partnership made no additional Portfolio Investments, but
made follow-on investments to existing Portfolio Companies of approximately
$718,000.  Cash distributions of $1,000,000 were made to the Limited Partners
and operations for the year resulted in a cash deficit of $472,448.    Since
the Partnership is in the process of being liquidated, it is anticipated by
the Trustee that the cash on hand should be sufficient for liquidation
purposes.

During 1999, the Partnership made no additional Portfolio Investments, but
made a follow-on investment to existing Portfolio Companies of approximately
$300,000 as part of an overal restructuring of its position in Tutogen.
Operations for the year resulted in a cash deficit of $275,017.    Since the
Partnership is in the process of being liquidated, it is anticipated by the
Trustee that the cash on hand should be sufficient for liquidation purposes.
It is the objective of the Trustee to distribute the stock in the Portfolio
Investments to the Partners in years 2000 and/or 2001.

RESULTS OF OPERATIONS

1999 COMPARED TO 1998
During 1999, the Partnership made no additional portfolio investments, but
made a follow-on investment to Tutogen Medical, Inc. of approximately $300,000
as a part of an overall restructuring of its position in Tutogen.  As a result
of prior investments and these follow-on investments, the Partnership incurred
net income of $8,864,368 in 1999, consisting of the following: (i) interest
income of $269,424; (ii) dividend income of $32,090; (iii)
management/director's fees of $1,107; (iv) total expenses of $377,924; (v)
realized gains on investments of $98,576 and (vi) unrealized appreciation on
investments of $8,841,095.  As a result of the liquidation of Portfolio
Companies, conversion of debentures to equity investments, and the necessity
of reserving interest accruals, interest income significantly declined in
1999.  Dividends are down as they are dependent on the availability of
Portfolio Companies' earnings for distribution.  The estimated value of
Portfolio Investments, as determined by the Trustee, indicates an increase of
$8,841,095 in fair value during 1999. Because the common stock of Tutogen is
the only remaining Partnership investment with material value, the market
price of that stock, and fluctuations therein, have a significant impact on
the Partnership's estimated value.  In that regard, Limited Partners should
recognize that Tutogen is a company with limited capitalization and trading
volume, and the market prices for such stock at any given time do not
necessarily reflect the price at which a substantial block of Tutogen common
stock could be bought or sold.  Accordingly, Limited Partners should recognize
that estimated values in this Report or in other documents regarding the
Partnership are necessarily imprecise and that the apparent value of the
Partnership is subject to potentially abrupt and unpredictable changes.
Because of the inherent uncertainty of valuations, the estimated Fair Value as
determined by the Trustee may vary significantly from the values that would
have been used had a ready market for the securities existed, and the
differences could be material.  (See Item 1.  Business - Narrative Description
of Business, and Partnership Portfolio Investments; and Item 13.  Certain
Relationships and Related Transactions).

The Trustee substantially lowered the expenses of the Partnership in 1999.
Total expenses incurred by the Partnership was $377,924 in 1999 compared to
$601,152 in 1998.

The Partnership incurred obligations to the Trustee of $72,000 for 1999.

In the third quarter of 1999, the Trustee accrued estimated legal fees of
$50,000 in anticipation of future legal activity related to the pending Coded
Communications matter. (see Item 3.  Legal Proceedings)

1998 COMPARED TO 1997
During 1998, the Partnership made no additional portfolio investments, but
made follow-on investments to existing Portfolio Companies of approximately
$718,000.  As a result of prior investments and these follow-on investments,
the Partnership incurred a net loss of $5,622,192 in 1998, consisting of the
following: (i) interest income of $354,888; (ii) dividend income of $16,217;
(iii) total expenses of $601,152; (iv) realized losses on investments of
$310,834 and (v) unrealized depreciation on investments of $5,087,413.  As a
result of the liquidation of portfolio companies, conversion of debentures to
equity investments, and the necessity of reserving interest accruals, interest
income seriously declined in 1998.  Dividends were down as they are dependent
on the availability of Portfolio Companies earnings for distribution.  The
estimated value of Portfolio Investments, as determined by the Trustee,
indicated a decrease of $5,087,413 in fair value during 1998.  Because of the
inherent uncertainty of valuations, the estimated Fair Value as determined by
the Trustee may vary significantly from the values that would have been used
had a ready market for the securities existed, and the differences could be
material.  (See Item 1.  Business - Narrative Description of Business, and
Partnership Portfolio Investments; and Item 13.  Certain Relationships and
Related Transactions).

The Partnership incurred obligations in 1998 for the quarterly management fees
through September 30, 1998, to the Partnership's then Managing General Partner
of $251,199, and the Independent General Partners of $49,283. The Partnership
reimbursed the Managing General Partner $99,055 for expenses in accordance
with the Investment Advisory Agreement. The Partnership incurred obligations
to the Trustee of $18,000 for the fourth quarter of 1998.

Distributions in the amount of $1,000,000 were paid to Limited Partners in
1998.

YEAR 2000
The Partnership experienced no material problems associated with Year 2000
issues.

ITEM 7(A).  QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

The Partnership is subject to financial market risks such as changes in
marketable equity security prices.  The Partnership does not use derivative
financial instruments to mitigate any of these risks.  The return on the
Partnership's investments is generally not affected by foreign currency
fluctuations.

A portion of the Partnership's portfolio consists of debt and equity
investments in a private company.  The Partnership would anticipate no impact
on this investment from modest changes in public market equity prices.
However, should significant changes in market prices occur, there could be a
longer-term effect on valuations of private companies which could affect the
carrying value and the amount and timing of proceeds realized on this
investment.

A significant portion of the Partnership's investment portfolio consists of
common stocks, and in one case warrants to purchase common stock, in publicly
traded companies.  These investments are directly exposed to equity price
risk, in that a percentage change in the prices of these equities would result
in a similar percentage change in the fair value of the Partnership's
investment in those securities.

ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

For the Index to Financial Statements; see "Index to Financial Statements" on
page F-1.

ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.

On April 22, 1999, the Partnership engaged the accounting firm of Smith,
Jackson, Cooper, and Daniell, PLLC ("Smith Jackson") to audit the
Partnership's financial statements for the fiscal year ended December 31,
1999, to replace the firm of KPMG LLP ("KPMG"), which was the principal
independent accountant for the Partnership's certified financial statements
since 1991.

In connection with the audits of the last two fiscal years ended December 31,
1998, there were no disagreements with KPMG on any matter of accounting
principles or practices, financial statement disclosure or auditing scope or
procedure, which disagreements if not resolved to the satisfaction of KPMG
would have caused that firm to make reference to the subject matter of the
disagreement in connection with its reports.

On October 1, 1998, the Partnership was sent into liquidation.   It is the
goal of the liquidation Trustee to minimize the expenses of the Partnership.
In order to lower the accounting fees incurred by the Partnership the Trustee
approved the engagement of the firm of Smith Jackson.

KPMG's report on the financial statements of the Partnership for the past two
fiscal years contained no adverse opinion or disclaimer of opinion and was not
qualified as to uncertainty, audit scope or accounting principles.

The Partnership requested that KPMG furnish it with a letter addressed to the
Commission stating whether it agreed with the above statements.  A copy of
KPMG's letter is filed as Exhibit D to this Report.

During fiscal 1998 and 1997, prior to their appointment as certifying
accountants, the Partnership did not consult Smith Jackson regarding any of
the matters or events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-
K.

                                    PART  III

ITEM 10.  DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

(1)  BACKGROUND AND EXPERIENCE OF DIRECTOR AND OFFICERS OF RENAISSANCE GROUP
Renaissance Group served as Managing General Partner of the Partnership
through September 30, 1998. The following table sets forth certain information
regarding the directors and officers of Renaissance Group.

Name:                   Position:
______________________________________________________________________________
Russell Cleveland       Chairman, President, Chief Executive Officer, and
                             Director
Barbe Butschek          Senior Vice President, Treasurer and Secretary
Robert C. Pearson       Senior Vice President - Corporate Finance
John A. Schmit          Vice President - Portfolio Monitoring

Russell Cleveland, age 62, is the principal founder and the majority
shareholder of Renaissance Group.  He is a Chartered Financial Analyst with
over thirty years experience as a specialist in investments for smaller
capitalization companies.  Mr. Cleveland currently serves as a director of
Greiner Engineering, Inc. (NYSE), a former portfolio investment of a prior
Renaissance Group investment partnership.  A graduate of the Wharton School of
Business, Russell Cleveland has served as President of the Dallas Association
of Investment Analysts.  Mr. Cleveland also serves on the board of Directors
of the following companies:  Biopharmaceutics, Inc., Global Environmental,
Inc., International Movie Group, Inc. and Tutogen Medical, Inc.

Barbe Butschek, age 46, has been associated with Renaissance Group and its
predecessor companies since 1977. As Senior Vice President, Secretary and
Treasurer, she has been responsible for office management, accounting
management and records management of the series of investor limited
partnerships.  Ms. Butschek supervises investor records and information with
respect to Renaissance Group and its funds.  She also prepares and maintains
investor tax and information reports.  Barbe Butschek serves as Secretary for
the Partnership and Renaissance Capital Partners, Ltd. and as Secretary and
Treasurer of Renaissance Capital Growth & Income Fund III, Inc.  She also
serves as Secretary of RenCap Securities, Inc., a wholly-owned subsidiary of
Renaissance Group and registered Broker-Dealer.

Robert C. Pearson, age 65, joined Renaissance Group in April 1997.  Mr.
Pearson brings over thirty years of experience to Renaissance Group's
corporate finance function. From May, 1994, to May, 1997, Mr. Pearson was an
independent financial management consultant.  From May, 1990, to May, 1994, he
served as Chief Financial Officer and Executive Vice President of Thomas
Group, Inc., a management consulting firm, where he was instrumental in moving
a small privately held company from a start-up to a public company with over
$40 million in revenues.  Prior to 1990, Mr. Pearson was responsible for all
administrative activities for the Superconducting Super Collider Laboratory.
In addition, from 1960 to 1985, Mr. Pearson served in a variety of positions
at Texas Instruments in financial planning and analysis, holding such
positions as Vice President-Controller and Vice President-Finance.  Mr.
Pearson holds a BS in Business from the University of Maryland and was a W.A.
Paton scholar with an MBA from the University of Michigan.

John A. Schmit, age 33, joined Renaissance Group initially as an independent
contractor in May, 1997, and, in October, 1997, he was appointed as Vice
President - Portfolio Monitoring. Prior to joining Renaissance Group, Mr.
Schmit worked as an independent contractor handling investments and monitoring
investment portfolios from February, 1996, to May, 1997.  From October, 1994,
to February 1996, he attended The Georgetown University Law Center and, from
September, 1992, to September, 1994, he practiced law at the law firm of
Gibson, Ochsner & Adkins.  He holds a BBA in Finance from Texas Christian
University, a JD from the University of Oklahoma College of Law and an LLM in
International and Comparative Law from The Georgetown University Law Center.

(2)  INFORMATION REGARDING LIQUIDATION TRUSTEE
Thomas W. Pauken, age 57, has experience both as a corporate executive officer
and as the head of an independent federal agency.  Professionally qualified as
an attorney, he currently is the President of TWP, Inc.  From 1985 to 1991,
Mr. Pauken was Vice President and Corporate Counsel of Garvon, Inc., a Dallas-
based venture capital company.  Mr. Pauken served on President Reagan's
transition team and on the White House legal counsel's staff.  Later, he was
appointed by President Reagan as Director of ACTION, an independent federal
agency that encourages volunteerism, where he served from 1981 to 1985.  He
also served as a White House staff assistant and as Associate Director of the
White House Fellowship program from 1970 to 1971.  Mr. Pauken served from 1986
to 1991 as Director of 50-off Stores, Inc.  He became a member of the Board of
Tutogen Medical, Inc. in January, 1999.  He also is a Board member of Hitox
Corporation of America.  He holds a BA in political science from Georgetown
University and a JD degree from Southern Methodist University School of Law.

(3)  INFORMATION REGARDING GENERAL PARTNERS
Mr. Ernest C. Hill and Mr. Thomas W. Pauken served as the Independent General
Partners of the Partnership until September 30, 1998, when Mr. Hill resigned
and Mr. Pauken agreed to become the Trustee of the Partnership. Under the
provisions of the 1940 Act, a majority of the general partners of the
Partnership must be "disinterested" or "non-affiliated" general partners.
Generally, any party that is involved in the daily activities of the
Partnership's business, including the Managing General Partner, as well as its
officers, directors and other affiliated persons, any investment adviser, any
accountant for the Partnership and any legal adviser, is considered an
"interested" party.  The Independent General Partners provided overall
guidance and supervision with respect to the operations of the Partnership and
perform various duties imposed on them under the 1940 Act.  Renaissance Group
was the Managing General Partner of the Partnership and also served as the
investment adviser to the Partnership until September 30, 1998, pursuant to
the Investment Advisory Agreement effective May 30, 1990, as subsequently
amended and restated, between the Partnership and Renaissance Group (the
"Advisory Agreement").  Renaissance Group is a registered investment adviser
under the Investment Advisers Act of 1940, as amended, and is subject to the
reporting and other requirements thereof.  As Managing General Partner,
Renaissance Group managed the day-to-day business and operations of the
Partnership until September 30, 1998.  The Partnership has no officers or
directors.  Renaissance Group and its officers and employees devoted such time
to the Partnership's business as was necessary for the conduct of the
Partnership's operations.  Since October 1, 1998, the Trustee has managed the
day-to-day business and operations of the Partnership.

Neither Renaissance Group nor its affiliates are prohibited from engaging in
activities outside the Partnership's business.  Renaissance Group serves as
Managing General Partner and Investment Advisor for Renaissance Capital
Partners, Ltd. ("Renaissance I"), a business development company with goals
and operations comparable to those of the Partnership.  Renaissance Group also
serves as investment advisor to Renaissance Capital Growth & Income Fund III,
Inc. ("Renaissance III"), a closed-end business development company listed on
the Nasdaq National Market with goals and operations comparable to those of
the Partnership.  Renaissance Group is also the Manager of Renaissance U.S.
Growth and Income Trust, PLC, an investment trust listed on the London Stock
Exchange, which invests primarily in privately placed convertible debentures
in U.S. public corporations.

BACKGROUND AND EXPERIENCE OF INDEPENDENT GENERAL PARTNERS
Mr. Ernest C. Hill, age 61, has a broad background in convertible securities
analysis with major NYSE brokerage firms and institutional investors.  He
specializes in computer-aided investment analysis and administrative
procedures. Mr. Hill was awarded a Ford Fellowship to Stanford School of
Business where he received an MBA, with honors, in Investment and Finance.
Mr. Hill's prior experience includes service as Assistant Professor of
Finance, Southern Methodist University, and Associate Director of the
Southwestern Graduate School of Banking.

Biographical information regarding Mr. Pauken appears above under the caption
"Information Regarding Liquidation Trustee".

ITEM 11.  EXECUTIVE COMPENSATION

Pursuant to the Advisory Agreement, Renaissance Group was entitled to receive
a quarterly management fee of 0.5% of Partnership assets and an annual
incentive fee equal to 20% of the Partnership's net realized capital gains
after allowance for unrealized depreciation and after the Limited Partners
have received a 10% annual return on their capital contributions (less
brokerage fees and commissions incurred by the Partnership on behalf of such
Limited Partner or Limited Partners).  In addition, the Partnership was
obligated to pay any direct costs, such as fees of any legal, accounting or
other professional advisors, and any travel, phone and other allocated
expenses incurred on behalf of the Partnership.  Neither the management fee
nor the incentive fee can be increased except with the affirmative vote of the
holders of a majority of the outstanding Units.  Renaissance Group agreed to
reduce its fees, if and to the extent necessary on a yearly basis, to limit
the total annual expense of the Partnership to an amount not greater than
2.75% of assets.

Renaissance Group withdrew as Managing General Partner of the Partnership as
of September 30, 1998, and no longer serves as Investment Advisor to the
Partnership.  From January 1, 1998, to September 30, 1998, the Partnership
paid Renaissance Group $251,199 in management fees charged to the Partnership
by Renaissance Group for the first nine months of 1998.  Renaissance is no
longer entitled to receive any management fees or incentive fees.

During the first nine months of 1998, the Independent General Partners, Ernest
C. Hill and Thomas W. Pauken, were compensated for their services pursuant to
the Partnership Agreement in an amount of $24,641 each.  Those payments ceased
as of October 31, 1998.  Thereafter, the Trustee was entitled to be
compensated at an amount of $6,000 per month for a total of $18,000 for his
services through December 31, 1998 and $72,000 for his services in 1999.  The
Trustee also is entitled to full reimbursement of all reasonable expenses
relative to his service on behalf of the Partnership; and he may be entitled
to additional compensation for his services subject to the improvement in the
value of the assets of the Partnership during the liquidation period.  Mr.
Pauken is a director of Tutogen Medical, Inc. and, in that capacity, he is
compensated by Tutogen along with other directors through the payment of
director's fees and the grant of stock options.

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

As of December 31, 1999, Renaissance Group and Thomas W. Pauken, Trustee, did
not own any Units of the Partnership.  The following table sets forth
information concerning the number of Units of the Partnership beneficially
owned as of December 31, 1999, by (i) the persons who, to the knowledge of the
Trustee, beneficially owned more than 5% of the outstanding Units, (ii) each
director or executive officer of Renaissance Group, and (iii) the directors
and executive officers as a group:
<TABLE>
<CAPTION>
Name and Address of            Units Beneficially       Percent of Total Units
  Beneficial Owner                   Owned                     Outstanding
______________________________________________________________________________
<S>                                  <C>                           <C>
HEB Investment and                    3,160                        7.34%
Retirement Plan Trust
P.O. Box 839999
San Antonio, Texas 78212

Russell Cleveland                       153                          *
8080 N. Central Expressway
Dallas, Texas 75206

Barbe Butschek                           0                           *
8080 N. Central Expressway
Dallas, Texas 75206

Robert C. Pearson                        0                           *
8080 N. Central Expressway
Dallas, Texas 75206

John A. Schmit                           0                           *
8080 N. Central Expressway
Dallas, Texas 75206
<FN>
*All directors and executive  153
officers as a group (5 persons).
</FN>

Thomas W. Pauken                         0                           *
Liquidation Trustee
5646 Milton St., Ste. 900
Dallas, Texas 75206

<FN>
* Less than 1%.     To the Trustee's knowledge, no other person beneficially
owned 5% or more of the outstanding Units.
</FN>
</TABLE>

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Pursuant to the Advisory Agreement, Renaissance Group served as managing
general partner and as investment adviser to the Partnership, subject to the
supervision of the Independent General Partners until September 30, 1998.
Services provided to the Partnership included the valuation of assets of the
Partnership, upon which the management fee paid to Renaissance Group is based
in part.  Renaissance Group believes that the valuations of portfolio
securities were performed in accordance with generally accepted accounting
principles and financial reporting policies of the Securities and Exchange
Commission.

Renaissance Group also provided services to Portfolio Companies from time to
time, pursuant to the Advisory Agreement.  Generally, the management fees
received by Renaissance Group for services to a Portfolio Company were paid to
the account of the Partnership, however, occasionally Renaissance Group
provided unusual services for a Portfolio Company that are unrelated to and
not required under the terms of the investment by the Partnership in such
Portfolio Company.  Fees for such services were paid directly to Renaissance
Group, subject to the limitations and requirements imposed by the 1940 Act.

Renaissance Group has formed, and may form in the future, other investment
funds to make investments in companies similar to those in which the
Partnership invests, including Renaissance Capital Partners, Ltd., a limited
partnership, Renaissance Capital Growth & Income Fund III, Inc., a business
development company, and Renaissance U.S. Growth & Income Trust PLC, a public
limited company registered in England and Wales whose shares are listed on the
London Stock Exchange.  Renaissance Group, and certain of its affiliates and
subsidiaries, also provide investment advisory services, management consulting
services and investment banking services to these entities.

                                    PART   IV

ITEM 14.  EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES, AND REPORTS ON FORM 8-K

Documents filed as part of this Form 10-K

FINANCIAL STATEMENTS:
The financial statements filed as part of this report are listed in "Index to
Financial Statements" on page F-1 hereof.

FINANCIAL STATEMENT SCHEDULES:
Not applicable.

REPORTS ON FORM 8-K:
Registrant did not file a report on Form 8-K during the fourth quarter of
1999.

EXHIBITS:
A.  Liquidation Trustee Agreement - Agreement for Engaging the Services of
Thomas W. Pauken as Liquidation Trustee of Renaissance Capital Partners II,
Ltd. (1)

B.  Renaissance Capital Partners II, Ltd. Amended and Restated Agreement and
Articles of Limited Partnership dated as of September 30, 1991.  (2)

C. Investment Advisory Agreement as of May 30, 1990, as amended and restated
on September 30, 1991, and March 7, 1994.   (2) (3)

D.  KPMG LLP letter dated March 9, 2000, addressed to the Commission regarding
changes in accountants.

_________________
(1)  Incorporated by reference from Exhibit 6.1 to Form 10-Q for quarterly
period ended September 30, 1998.

(2)  Incorporated by reference from Form N-2 as filed with the Securities and
Exchange Commission on October 21, 1991 (Registration No. 33-38593).

(3)  Incorporated by reference from Registrant's 1998 proxy filed with the
Securities and Exchange Commission on or around April 20, 1998.



                                    SIGNATURES

Pursuant to the requirements of Section 13 of 15(d) of the Securities Exchange
Act of 1934, the Registrant had duly caused this report to be signed on its
behalf by the undersigned, there unto duly authorized.

Date:  March 22, 2000
                                      RENAISSANCE CAPITAL PARTNERS II, LTD.
                                             (Registrant)


                                      By:	      /S/
                                          __________________
                                          Thomas W. Pauken
                                          Liquidation Trustee

<PAGE>

INDEX TO FINANCIAL STATEMENTS


                                                            Page

Independent Auditors' Reports                          F-2 through F-3

Statements of Assets, Liabilities
and Partners' Equity December 31, 1999 and 1998             F-4

Statements of Investments -
December 31, 1999 and 1998                             F-5 through F-8

Statements of Operations -
Years ended December 31, 1999, 1998 and 1997                F-9

Statements of Partners' Equity -
Years ended December 31, 1999, 1998 and 1997                F-10

Statements of Cash Flows -
Years ended December 31, 1999, 1998 and 1997                F-11

Notes to Financial Statements                         F-12 through F-17

<PAGE>

                   SMITH, JACKSON, COOPER & DANIELL,  P.L.L.C.
                         Independent Auditors' Report


The Partners
Renaissance Capital Partners II, Ltd.:

We have audited the accompanying statement of assets, liabilities and
partners' equity of Renaissance Capital Partners II, Ltd. (a Texas Limited
Partnership), including the statement of investments, as of December 31,
1999, and the related statements of operations, partners' equity, and cash
flows for the year then ended.  These financial statements are the
responsibility of the Partnership's management.  Our responsibility is to
express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing
standards.  Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free
of material misstatement.  An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements.
Our procedures included verification and confirmation of investments owned as
of December 31, 1999, by examination of securities held in safekeeping for
the Partnership and correspondence with the custodian.  An audit also
includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation.  We believe that our audit provides a reasonable basis for our
opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Renaissance Capital Partners
II, Ltd. as of December 31, 1999, and the results of its operations and its
cash flows for the year then ended, in conformity with generally accepted
accounting principles.





             SMITH, JACKSON, COOPER & DANIELL
             A Professional Limited Liability Company


Dallas, Texas
January 19, 2000


<PAGE>


                                    KPMG  LLP

                          Independent Auditors' Report


The Partners
Renaissance Capital Partners II, Ltd.:

We have audited the accompanying statements of assets, liabilities and
partners' equity of Renaissance Capital Partners II, Ltd. (a Texas Limited
Partnership), including the statements of investments, as of December 31,
1998, and the related statements of operations, partners' equity, and cash
flows for each of the years in the two-year period ended December 31, 1998.
These financial statements are the responsibility of the Partnership's
management.  Our responsibility is to express an opinion on these financial
statements based on our audits.

We conducted our audits in accordance with generally accepted auditing
standards.  Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free
of material misstatement.  An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements.
Our procedures included verification and confirmation of investments owned as
of December 31, 1998, by examination of securities held in safekeeping for
the Partnership.  An audit also includes assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation.  We believe that our audits provide
a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Renaissance Capital Partners
II, Ltd. as of December 31, 1998, and the results of its operations and its
cash flows for each of the years in the two-year period ended December 31,
1998, in conformity with generally accepted accounting principles.





                                KPMG LLP


Dallas, Texas
February 12, 1999

<PAGE>

<TABLE>
<CAPTION>
STATEMENT OF ASSETS, LIABLITIES, AND PARTNERS' EQUITY
DECEMBER 31, 1999 AND 1998

            Assets
                                                  1999                 1998
<S>                                                <C>                  <C>
Cash and cash equivalents                    $  1,012,358         $ 1,239,015
Short term investments                            100,000                 -
Investments at fair value, cost of
  $8,066,598 in 1999 and $21,607,598
      in 1998 (note 4)                         15,634,975           6,568,982
Interest receivable                                 2,315             103,022
Other assets                                       30,898               6,396
                                              ___________          __________

                                             $ 16,780,546         $ 7,917,415
                                              ===========          ==========

           Liabilities and Partners' Equity

Liabilities:
  Accounts payable                               $ 27,946            $ 41,587
  Accounts payable - affiliate (note 3)              -                 37,596
  Accrued Liabilities                              50,000                 -
                                              ___________          __________
       Total liabilities                           77,946              79,183
                                              ___________          __________
Partners' equity (note 5):
  General partner                                     -                   -
  Limited partners (outstanding units
   of 43254.01 in 1999 and 1998)               16,702,600           7,838,232
                                              ___________          __________

      Total partners' equity                   16,702,600           7,838,232

Commitments and contingencies
    (notes 3 and 4)
                                              ___________          __________

                                             $ 16,780,546         $ 7,917,415
                                              ===========          ==========
Limited partners' equity per limited
  partnership unit                                  $ 386               $ 181
                                              ===========          ==========
<FN>
See accompanying notes to financial statements.
</FN>



<PAGE>

<CAPTION>
STATEMENTS OF INVESTMENTS
DECEMBER 31, 1999 AND 1998
                                                       1999
                                  ___________________________________________
       	                            Interest  Due                       Fair
                                    Rate      date        Cost          Value
                                  ___________________________________________
<S>                                 <C>       <C>          <C>           <C>
Eligible Portfolio Investments -
  Convertible Debentures and
  Notes Receivable (1)

Central PA Rehabilitation
  Services, Inc. - physical
  therapy rehabilitation centers:
      Note receivable              9.00%    Varies     $ 79,415       $ 9,415


Tutogen Medical, Inc. (formerly
  Biodynamics International,
  Inc.) - specialty surgical
  products:

      Convertible debenture        9.00%  11/11/02    $ 500,000     $ 500,000

                                                      _________     _________

                                                        579,415       579,415

                                                      _________     _________


<PAGE>
<CAPTION>
STATEMENT OF INVESTMENTS
DECEMBER 31, 1999 AND 1998

                                                         1999
                                  ___________________________________________
                                                                      Fair
                                    Shares              Cost          Value
                                  ___________________________________________
<S>                                  <C>                 <C>           <C>

Eligible Portfolio Investments -
  Common and Preferred Stock and
    Warrants (1)

Tutogen Medical, Inc.
 (formerly Biodynamics
  International, Inc.) -
  specialty surgical products:
    Common                           5,735,451     $  7,487,183   $ 15,055,560

    Warrants to purchase
       547,560 shares of
       Tutogen Medical, Inc.           547,560               -              -


    Warrants to purchase
       806,396 shares of
       Tutogen Medical, Inc.           806,396               -              -


    Warrants to purchase
       400,000 shares of
       Tutogen Medical, Inc.           400,000               -              -


    Warrants to purchase
       300,000 shares of
       Tutogen Medical, Inc.           300,000               -              -

                                                      7,487,183     15,055,560
                                                    ___________   ____________

                                                    $ 8,066,598   $ 15,634,975
                                                    ===========   ============

<FN>
<FN1>
(1) Valued at fair value as determined by the Trustee (note 4).

<FN2>
See accompanying notes to financial statements.
</FN>


<PAGE>
<CAPTION>
STATEMENTS OF INVESTMENTS
DECEMBER 31, 1999 AND 1998

                                                         1998
                                _____________________________________________

                                    Interest  Due                       Fair
                                    Rate      date        Cost          Value
                                _____________________________________________
<S>                                 <C>       <C>         <C>             <C>

Eligible Portfolio Investments -
  Convertible Debentures and
  Notes Receivable (2)

Coded Communications Corporation -
  digital data transmission
  equipment manufacturers:
     Note receivable (1)            6.00%   03/01/99   $ 311,060    $ 311,060


Consolidated Health Care
  Associates Inc. - physical
  therapy rehabilitation
  centers: (1)
     Notes receivable           8.00-15.00   Varies    1,182,938      105,736


Protech, Inc. -
   telecommunications:
     Convertible debenture (1)     10.00    09/30/99      67,500          -


Tricom Corporation -
   telecommunications network
   construction:
     Promissory note (1)             -      12/31/99      50,000          -


Tutogen Medical, Inc.
   (formerly Biodynamics
   International, Inc.)
   - specialty surgical products:
     Convertible debentures (1)     9.00    11/11/02   2,574,081     5,326,743
                                                       _________     _________


                                                       4,185,579     5,743,539
                                                       _________     _________


<PAGE>
<CAPTION>
STATEMENTS OF INVESTMENTS
DECEMBER 31, 1999 AND 1998
                                                        1998
                                _____________________________________________
                                                                      Fair
                                    Shares              Cost          Value
                                _____________________________________________

<S>                                  <C>                 <C>           <C>

Eligible Portfolio Investments -
  Common and Preferred Stock and
    Warrants (2)

Coded Communications, Corporation
- digital data transmission
equipment manufacturers:
    Series A convertible
      preferred                     4,445            $ 410,343      $     -
    Series B convertible
      Preferred                    46,775            4,244,245            -
      Common                    1,014,585              517,025            -



Consolidated Health Care
  Associates, Inc. - physical
  therapy rehabilitation
  centers: (1)
    Series A preferred          1,195,984            1,195,984            -
    Series B preferred            500,000              500,000            -
    Common                      5,000,000            2,500,000            -


Total Choice, Inc. - premium
  Incentive fulfillment
  company:
    Preferred                       3,000              300,000            -
    Common                            500              700,000            -


Tricom Corp. - telecommunications
  network construction:
    Common                      1,093,955            2,203,600            -


Tutogen Medical, Inc.
  (formerly Biodynamics
  International, Inc.) -
  specialty surgical products:
     Common                       695,110            4,850,822        825,443
     Warrants to purchase
     547,560 shares
     of Tutogen Medical, Inc.     547,560                   -             -
     Warrants to purchase
     806,396 shares
     of Tutogen Medical, Inc.     806,396                   -             -
     Warrants to purchase
     400,000 shares
     of Tutogen Medical, Inc.     400,000                   -             -
                                                  ____________   ____________

                                                    17,422,019        825,443

                                                  ____________   ____________

                                                  $ 21,607,598    $ 6,568,982

                                                  ============   ============
<FN>
<FN1>
(1)  Interest or dividend payments under the terms of the convertible
debenture, note receivable or preferred stock were delinquent as of December
31, 1998.
<FN2>
(2) Valued at fair value as determined by the Trustee (note 4).
</FN>

<PAGE>
<CAPTION>
STATEMENTS OF OPERATIONS
YEARS ENDED DECEMBER 31, 1999, 1998 AND 1997


                                          1999	        1998          1997
                                     ________________________________________
Income:
  Interest                             $ 269,424     $ 354,888    $ 745,190
  Dividends                               32,090        16,217       49,690
  Commitment, closing and
     management fees                       1,107         6,102           -
                                      __________    __________   __________
                                         302,621       377,207      794,880
                                      __________    __________   __________

Expenses (note 3):
  General and administrative             305,924       331,953      309,042
  Trustee Fees                            72,000        18,000           -
  Management fees                             -        251,199      411,179
                                      __________    __________   __________
                                         377,924       601,152      720,221
                                      __________    __________   __________
       Operating (loss) income          (75,303)     (223,945)       74,659
                                      __________    __________   __________
Investment loss:
  Net unrealized appreciation
   (depreciation) on investments
   (note 4)                            8,841,095   (5,087,413)  (10,630,309)
  Net realized gain (loss)
    on investments                        98,576     (310,834)     (550,959)
                                      __________    __________   __________
           Investment gain (loss)      8,939,671   (5,398,247)  (11,181,268)
                                      __________    __________   __________
           Net income (loss)         $ 8,864,368  $(5,622,192) $(11,106,609)
                                      ==========    ==========   ==========
Limited Partners' share of net
  income (loss) $204.94, $(129.94)
  and $(253.01) per unit for 1999,
  1998 and 1997, respectively        $ 8,864,368  $(5,622,192) $(10,964,650)

General Partner's share of
  net loss                                    -             -      (141,959)
                                      __________    __________   __________
          Net income (loss)          $ 8,864,368  $(5,622,192) $(11,106,609)
                                      ==========    ==========   ==========

<FN>
See accompanying notes to financial statements.
</FN>

<PAGE>
<CAPTION>
STATEMENT OF PARTNERS' EQUITY
YEARS ENDED 31, 1999, 1998 AND 1997

                                  General          Limited
                                  Partner          Partners          Total
                               ___________       ___________      __________
<S>                                <C>              <C>               <C>
Balance, December 31, 1996       $(56,010)       $26,728,853     $26,672,843

  Redemption of 130 limited
  partnership units                    -            (79,366)        (79,366)

  Net loss                       (141,959)      (10,964,650)    (11,106,609)

  Distributions (note 5)               -         (1,000,000)     (1,000,000)
                               ___________       ___________      __________

Balance, December 31, 1997       (197,969)        14,684,837      14,486,868

  Redemption of 50 limited
  partnership units                    -            (26,444)        (26,444)

  Net loss                             -         (5,622,192)     (5,622,192)

  Distributions (note 5)               -         (1,000,000)     (1,000,000)

  Dissolution adjustment
   (note 5)                       197,969          (197,969)             -
                               ___________       ___________      __________

Balance, December 31, 1998             -           7,838,232       7,838,232

  Net income                           -           8,864,368       8,864,368
                               ___________       ___________      __________

Balance, December 31, 1999      $      -        $ 16,702,600    $ 16,702,600
                               ===========       ===========      ==========
<FN>
See accompanying notes to financial statements.
</FN>

<PAGE>
<CAPTION>
STATEMENTS OF CASH FLOWS
YEARS ENDED 1999, 1998 AND 1997

                                     1999           1998           1997
                                 _________________________________________
<S>                                  <C>            <C>            <C>
Cash flows from operating
activities:

 Net income (loss)              $ 8,864,368     $(5,622,192)   $(11,106,609)

 Adjustments to reconcile net
 income (loss) to net cash used
 in operating activities:
   Net unrealized (appreciation)
    depreciation on investments  (8,841,095)       5,087,413      10,630,309
   Net realized gain (loss)
    on investments                  (98,576)         310,834         550,959
  (Increase) decrease in
    other assets                    (24,502)         (6,396)         103,252
   Increase (decrease) in
    interest receivable	           (173,975)       (176,793)       (550,599)
   Increase (decrease) in
    accounts payable                (13,641)          17,644        (33,274)
   Decrease in accounts
    payable - affiliate             (37,596)        (82,958)        (82,808)
   Increase in accrued
    Liabilities                      50,000               -              -
                                 ___________     ___________     ___________

           Net cash used in
           operating activities    (275,017)       (472,448)       (488,770)
                                 ___________     ___________     ___________
Cash flows from investing
activities:
 Purchase of investments           (300,000)       (718,386)     (3,131,000)
 Proceeds from sale of
  Investments                        110,979       1,708,138       3,773,121
 Repayment of principal
  on investments                     337,381             -             1,000
 Investments in short term
  investments, net                 (100,000)         992,400       (992,400)
                                 ___________     ___________     ___________
            Net cash provided by
            (used in) investing
            activities               48,360        1,982,152       (349,279)
                                 ___________     ___________     ___________
Cash flows from financing
activities:
 Redemption of limited
  partnership units                      -          (26,444)        (79,366)
 Distributions to limited
  Partners                               -       (1,000,000)     (1,000,000)
                                 ___________     ___________    ___________
            Net cash used in
            financing activities         -       (1,026,444)     (1,079,366)
                                 ___________     ___________    ___________
Net increase (decrease) in cash
 and cash equivalents              (226,657)        483,260      (1,917,415)
Cash and cash equivalents at
 beginning of the year            1,239,015         755,755       2,673,170
                                 ___________     ___________     ___________
Cash and cash equivalents at
end of the year                  $1,012,358      $1,239,015      $  755,755
                                 ===========     ===========     ===========

Noncash investing transactions:

During 1999, the Partnership exercised its right to convert a debenture in
the principal amount of	$2,074,081 to 4,600,507 shares of common stock of
Tutogen Medical, Inc.

During 1999, 1998, and 1997, $274,682, $127,911, and $610,616, respectively,
of interest receivable was capitalized to convertible debentures, notes
receivable or common stock.

During 1999, investment costs of $13,765,899 were permanently written-down
against valuation reserves.

<FN>
See accompanying notes to financial statements.
</FN>
</TABLE>


<PAGE>

[FN]
(1)  ORGANIZATION AND BUSINESS PURPOSE

Renaissance Capital Partners II, Ltd. (the "Partnership"), a Texas limited
partnership, was formed in 1991.  The Partnership offered to sell units of
limited partners' interest ("Units") in the Partnership.  Net contributions
of $39,064,847 from sale of Units had been received upon final closing of the
Partnership on March 31, 1993.  The Partnership seeks to achieve current
income and capital appreciation potential by investing primarily in private
placement convertible debt investments of small and medium size companies
which are in need of capital and which the Managing General Partner believes
offer the opportunity for growth.  The Partnership has elected to be treated
as a business development company under the Investment Company Act of 1940,
("1940 Act"), as amended.

On October 1, 1998 the Managing General Partner and the Independent General
Partners agreed to commence liquidation of the Partnership.  The Managing
General Partner withdrew from the Partnership and the Partnership appointed
an independent general partner as Liquidation Trustee (the "Trustee").  The
Trustee, pursuant to a Liquidation Trustee Agreement, assumed all
responsibilities and has the authority of the Managing General Partner.  The
Partnership will terminate upon liquidation of all of its investments, which
is anticipated to occur in 2001.


(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)  Valuation of Investments
Portfolio investments are stated at quoted market or fair value as determined
by the Trustee in 1999 and 1998, and by the Managing General Partner and
approved by the Independent General Partners in 1997 (note 4).  Most
securities held by the Partnership are unregistered and their value does not
necessarily represent the amounts that may be realized from their immediate
sale or disposition.

(b)  Statements of Cash Flows
The Partnership considers all highly liquid debt instruments with original
maturities of three months or less to be cash equivalents.

(c)  Net Income (Loss) per Limited Partnership Unit
Net income (loss) per limited partnership unit is based on the weighted
average number of limited partnership Units outstanding during the year.  The
weighted average limited partnership Units outstanding were 43,266.5 during
1999, 1998, and 1997.

(d)  Federal Income Taxes
In accordance with Federal income tax regulations, no income taxes are levied
in a partnership, but rather on the individual partners.  Consequently, no
Federal income taxes have been reflected in the accompanying financial
statements.

(e)  Short Term Investments
Short term investments represent a bank certificate of deposit with a maturity
date of 6 months.  Such investment was valued at cost, which approximates
market.

(f)  Commitment, Closing and Management Fees
Commitment, closing and management fees represent amounts charged to Eligible
Portfolio Companies for commitments to fund additional amounts under
convertible debenture agreements, closing of convertible debenture agreements
and management services provided by the Managing General Partner to Eligible
Portfolio Companies.  Such fees are recognized as income based on the terms
of the underlying convertible debenture agreements and management agreements.

(g)  Management Estimates
Management of the Partnership has made a number of estimates and assumptions
relating to the reporting of assets and liabilities and the disclosure of
contingent assets and liabilities to prepare these financial settlements in
conformity with generally accepted accounting principles.  Actual results
could differ from these estimates.

(h) Reclassifications
Certain reclassifications have been made to the 1998 Financial Statements to
conform to the 1999 presentation.

(3)  MANAGEMENT AND ORGANIZATION FEES

The Trustee receives a monthly fee of $6,000 for services performed in
connection with the liquidation of the Partnership.  Such fees totaled
$72,000 in 1999 and $18,000 in 1998.  Additionally, the Trustee receives
$4,000 monthly as reimbursement for administrative personnel.  All other
expenses incurred by the Trustee shall be charged to the Partnership as they
occur.

Renaissance Capital Group, Inc. (the "Managing General Partner"), served as
the investment adviser for the Partnership in 1998 and 1997.  The Managing
General Partner is registered as an investment adviser under the Investment
Advisers Act of 1940.  Pursuant to an Investment Advisory Agreement, the
Managing General Partner performed certain services, including certain
management, investment advisory and administrative services necessary for the
operation of the Partnership.  In addition, under this agreement, the
Managing General Partner was reimbursed by the Partnership for certain
administrative expenses.  A summary of fees and reimbursements paid by the
Partnership under the Investment Advisory Agreement and the original offering
document are as follows:

*  The Managing General Partner received a fee equal to one-half of one
percent (0.5%) of the Net Assets after the initial closing date of the
Partnership and was entitled to receive quarterly fees thereafter equal to
0.5% of Net Assets, as defined in the Partnership Agreement.  The Partnership
incurred, during the years ended December 31, 1998 and 1997, $251,199 and
$411,179, respectively, for such management fees.  For the years ended
December 31, 1998 and 1997, the Managing General Partner elected to calculate
the quarterly fee based on the lesser of contributed capital or Net Assets.
If the Managing General Partner had elected to calculate the quarterly fee
solely based on Net Assets, the fee would have been approximately $153,000
greater than the cumulative fee charged.

*  The Managing General Partner was reimbursed by the Partnership for
administrative expenses incurred by the Managing General Partner on behalf of
the Partnership.  Such reimbursements were $99,055 and $90,476, for the years
ended December 31, 1998 and 1997, respectively, and are included in general
and administrative expenses in the accompanying statements of operations.

Each of the Independent General Partners received a quarterly fee of $.24 per
unit for the first 25,000 units and $.12 per unit for all units in excess of
25,000 and reimbursement of expenses incurred on behalf of the Partnership.
Such amounts totaled $49,283 in 1998 and $65,710 in 1997 and are included in
general and administrative expenses in the accompanying statements of
operations.

(4)  INVESTMENTS

The Partnership invests in convertible debentures and other securities of
companies that qualify as Eligible Portfolio Companies as defined in Section
2(a)(46) of the 1940 Act or in securities that otherwise qualify for
investment as permitted in Section 55(a)(1) through (5) of the 1940 Act.
Under the provisions of the 1940 Act, as a business development company, at
least 70% of the Partnership's funds, as defined under the 1940 Act, must be
invested in Eligible Portfolio Companies.  Investments of the Partnership are
carried in the statements of assets, liabilities, and partners' equity at
quoted market or fair value, as determined in good faith by the Trustee at
December 31, 1999 and 1998, and the Managing General Partner and approved by
the Independent General Partners at December 31, 1997.

The debentures and preferred stock held by the Partnership are convertible, at
any time, into the common stock of the issuer at a set conversion price.  The
common stock acquired upon exercise of the conversion feature is generally
unregistered and is thinly to moderately traded, but is not otherwise
restricted.  The Partnership generally may register and sell such securities
at any time with the Partnership paying the costs of registration.  Interest
is generally payable monthly, and all debentures have sinking fund provisions
beginning three to four years from issue date.  The debentures generally have
call options, usually commencing three years subsequent to issuance, at
prices specified in the debenture agreements.

The Partnership Agreement and the original offering document specify that
securities held by the Partnership shall be valued as follows:

*  The Managing General Partner will, on a quarterly basis, prepare a
valuation of the Partnership assets, including the investment portfolio and
any other investments.

*  For securities that are publicly traded and for which quotations are
available, the Partnership will value the investments based on the closing
sale as of the last day of the fiscal quarter, or in the event of an interim
valuation, as of the date of the valuation.  If no sale is reported on such
date, the securities will be valued at the average of the closing bid and
asked prices.

*  Initially the investments will be primarily in nonpublicly-traded
convertible debentures, and in other instances the Partnership will hold
restricted securities.  Therefore, market quotations will not always be
available for investment valuation.  In such cases, the securities will be
valued by the Managing General Partner at estimated fair value pursuant to
the following standards:

Generally, debt securities will be valued at their face value.  However, if
the debt is impaired, an appropriate valuation reserve will be established or
the investment discounted to estimated realizable value.  For securities that
are in a class of publicly traded securities that are restricted from free
trading (such as Rule 144 securities), valuation will be established by
appropriately discounting the closing sales or bid price to reflect the
illiquidity caused by such restriction.

Conversely, if the underlying stock has appreciated in value and the
conversion feature justifies a premium value, such premium will of necessity
be recognized.  Further, if the known market value of a stock holding
indicates that an appreciated value may be realized on sale of a restricted
stock, such investment may be valued at such appreciated value regardless of
the fact that certain open-market sale restrictions apply.

*  The Managing General Partner, subject to the approval and supervision of
the Independent General Partners, will be responsible for determining fair
value.  In the event that the Independent General Partners do not agree with
the valuations established by the Managing General Partner, they may retain
independent firms to review the Managing General Partner's methodology of
valuation or to conduct a valuation, and such appraisal shall be binding on
the Partnership.

Upon commencement of liquidation, the Trustee is responsible for determining
fair value in a manner similar to the process detailed above.

As of December 31, 1999 and 1998, the Partnership held Eligible Portfolio
Investments with a market or fair value, as determined in good faith by the
Trustee at December 31, 1999 and 1998, of $12,829,070 and $6,568,982,
respectively.  Such values were determined using the methodology noted above.
The valuation methods specifically include the following.

*  Original cost
*  Quoted market value
*  The quoted market value of the underlying class of common stock that the
convertible debt or preferred stock may be converted into, less estimated
costs to sell and register the common stock
*  Original cost less a valuation reserve for collectibility concerns

The financial statements include investments valued at $15,634,975 (93% of
total assets) and $6,568,982 (83% of total assets) as of December 31, 1999
and 1998, respectively, whose values have been estimated by the Trustee in
the absence of readily ascertainable market values.  Because of the inherent
uncertainty of valuation, those estimated values may differ significantly
from the values that would have been used had a ready market for the
securities existed, and the differences could be material.

As of December 31, 1999 and 1998, the net unrealized appreciation
(depreciation) associated with investments held by the Partnership was
$7,568,377 and ($15,038,616), respectively.

During 1999, the Trustee permanently wrote-down investment costs of
$13,765,899 against existing valuation reserves.

(5)  PARTNERS' EQUITY

Pursuant to the terms of the Partnership Agreement, all items of income, gain,
loss and deduction of the Partnership, other than any Capital Transaction, as
defined in the Partnership Agreement, are allocated 1% to the Managing
General Partner and 99% to the Limited Partners, except prior to the initial
closing date when all items were allocated 99% to the Managing General
Partner and 1% to the Initial Limited Partner.

All items of net gain of the Partnership resulting from a Capital Transaction,
defined in the Partnership Agreement as a sale or disposition of any
portfolio investment (defined under the 1940 Act), are allocated such that
first the Limited Partners receive a cumulative simple annual return of 10%
on their gross capital contributions and any remaining capital gains (net of
capital losses and unrealized depreciation) are allocated 20% to the Managing
General Partner and 80% to the Limited Partners.  All items of net capital
loss resulting from Capital Transactions are allocated 1% to the Managing
General Partner and 99% to the Limited Partners.  As of December 31, 1998 and
1997, the net unrealized appreciation or depreciation was allocated 99% to
the Limited Partners.  If the investments in convertible debentures had been
disposed of at their estimated fair values, as determined by the Managing
General Partner and approved by the Independent General Partners, there would
have been no additional allocation to the Managing General Partner under the
terms of the Partnership Agreement and Investment Advisory Agreement.

In 1998 upon commencement of liquidation and withdrawal of the Managing
General Partner, the General Partner's deficit balance was reallocated to the
Limited Partners pursuant to the terms of the Partnership Agreement.

Distributions to the Limited Partners were made at the discretion of the
Managing General Partner, in accordance with the Partnership Agreement.  As a
result of decreasing cash resources in 1996, the distributions to the limited
partners were discontinued.  As the Partnership's investments were liquidated
or other cash resources were obtained, the Partnership reinstated such
payments in whole or in part during 1997 and 1998 based upon Capital
Transactions and the cash resources available.  In addition, the Managing
General Partner had the discretion to discontinue payment of the management
fees or expense reimbursements if cash resources were further limited.

Upon commencement of liquidation, distributions are made at the discretion of
the Trustee.
</FN>

<PAGE>
Exhibit D.


                                      KPMG  LLP





March 9, 2000


Securities and Exchange Commission
Washington, DC 20549


Ladies and Gentlemen:

We were previously principal accountants for Renaissance Capital Partners II,
Ltd. and, under the date of February 12, 1999, we reported on the financial
statements of Renaissance Capital Partners II, Ltd. as of December 31, 1998
and for each of the years in the three-year period ended December 31, 1998.
On August 23, 1999 our appointment as principal accountants was terminated.
We have read Renaissance Capital Partners II, Ltd. statements included under
Item 9 of its December 31, 1999 Form 10-K, and we agree with such statements,
except that we are not in a position to agree or disagree with Renaissance
Capital Partners II, Ltd.'s statement that Smith, Jackson, Cooper and
Daniell, PLLC was not engaged regarding the application of accounting
principles to a specified transaction or the type of audit opinion that might
be rendered on Renaissance Capital Partners II, Ltd.'s financial statements
nor are we in a position to agree or disagree with Renaissance Capital
Partners II, Ltd.'s statements that the change was approved by the Trustee.


Very truly yours,



KPMG LLP